deltatrials
Terminated PHASE3 INTERVENTIONAL 2-arm NCT04342221

Hydroxychloroquine for COVID-19 (COV-HCQ)

Randomized Controlled Trial of Hydroxychloroquine Versus Placebo for the Treatment of Adult Patients With Acute Coronavirus Disease 2019 - COVID-19

Sponsor: Bernhard Nocht Institute for Tropical Medicine

Conditions COVID-19, Hydroxychloroquine Sulfate
Interventions Hydroxychloroquine Sulfate Placebo
Updated 7 times since 2020 Last updated: Apr 28, 2021 Started: Mar 29, 2020 Primary completion: Feb 26, 2021 Completion: Feb 26, 2021
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Reduced acceptance of IMP

Other terminated trials from Bernhard Nocht Institute for Tropical Medicine

See all terminations from Bernhard Nocht Institute for Tropical Medicine

This PHASE3 trial investigates COVID-19, Hydroxychloroquine Sulfate and is currently terminated or withdrawn. Bernhard Nocht Institute for Tropical Medicine leads this study, which shows 7 recorded versions since 2020 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.

Status Flow

~May 2020 – ~Aug 2020 · 3 months · monthly snapshotRecruiting~Aug 2020 – ~Dec 2020 · 4 months · monthly snapshotRecruiting~Dec 2020 – ~Jan 2021 · 31 days · monthly snapshotRecruiting~Jan 2021 – ~Jun 2021 · 5 months · monthly snapshotRecruiting~Jun 2021 – ~Jul 2024 · 37 months · monthly snapshotTerminated~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotTerminated~Sep 2024 – present · 22 months · monthly snapshotTerminated

Change History

7 versions recorded

  1. Sep 2024 — Present [monthly]

    Terminated PHASE3

  2. Jul 2024 — Sep 2024 [monthly]

    Terminated PHASE3

  3. Jun 2021 — Jul 2024 [monthly]

    Terminated PHASE3

    Status: Recruiting → Terminated

  4. Jan 2021 — Jun 2021 [monthly]

    Recruiting PHASE3

  5. Dec 2020 — Jan 2021 [monthly]

    Recruiting PHASE3

▶ Show 2 earlier versions

  1. Aug 2020 — Dec 2020 [monthly]

    Recruiting PHASE3

  2. May 2020 — Aug 2020 [monthly]

    Recruiting PHASE3

    First recorded

Mar 2020

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Bernhard Nocht Institute for Tropical Medicine
  • Robert Bosch Medical Center
  • University Hospital Tuebingen
  • Universitätsklinikum Hamburg-Eppendorf
Data source: University Hospital Tuebingen

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations